Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose hypertension is either uncontrolled by or resistant to existing medicines.

The drug came to AstraZeneca through its acquisition of CinCor Pharma in 2023, with the hopes of beefing up its ...

AstraZeneca's new drug, baxdrostat, has successfully lowered blood pressure in a late-stage trial for treatment-resistant ...

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

Research shows that the damage from high blood pressure often happens slowly over many years. A study published in the New ...

AstraZeneca 's experimental drug baxdrostat has been successful in lowering high blood pressure in a late-stage study of ...

To tackle the issue of high salt consumption, the NIE has launched a three-year intervention project in Punjab and Telangana, ...

One in three adults in the U.S. has three or more risk factors for a newly recognized but increasingly common condition: ...

High doses of NSAIDs can be harmful to your kidneys, according to he National Kidney Foundation. The Foundation’s website ...

During an eye exam, an optometrist may be able to measure the diameter of blood vessels to determine if a person is likely to ...

High blood pressure can lead to serious problems like heart disease, strokes, and kidney disease so keeping it under control ...

Certain medications can affect your body's ability to tolerate hot weather. Diuretics, beta-blockers, and some antipsychotics ...